跳至主要内容
临床试验/NCT01624012
NCT01624012已完成不适用

Non-invasive Ventilation With Neurally Adjusted Ventilatory Assist (NIV NAVA) Versus Nasal Continuous Airway Pressure (NCPAP) in Premature Infants

University of Oulu2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2011年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
2
主要终点
Duration of inspired oxygen supply

研究概览

简要总结

The purpose of this study is to compare if a new noninvasive ventilation mode (NIV NAVA) is better in noninvasive ventilation of premature infants than currently used Nasal Continuous Airway Pressure (ncpap), and if NIV NAVA gives real benefits for patients or not.

The investigators study hypothesis is that with NIV NAVA the invasive ventilation is more synchronous with patient, which will lead to a decrease in need of inspired oxygen.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
1 Hour 至 48 Hours(Child)
性别
All
接受健康志愿者

入选标准

  • postconceptional age 28+0 - 36+6
  • need of ncpap treatment and inspired oxygen for at least 60 minutes

排除标准

  • severe birth asphyxia, malformation or chromosomal abnormality, or other condition, which will decrease life expectancy
  • any condition which prevents insertion of naso/orogastric tube

结局指标

主要结局

Duration of inspired oxygen supply

时间窗: 30minutes- 3weeks

Participants will be followed for the duration of hospital stay, an expected average of 3 weeks

次要结局

  • Duration of parenteral nutrition(3 weeks)
  • Blood gas analyses(3 weeks)
  • Duration of noninvasive ventilation(30 minutes - 3 weeks)
  • Fraction of inspired oxygen(0, 1, 3 and 6hours, after which every 6 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Merja Ålander

Principal investigator

University of Oulu

研究点 (2)

Loading locations...

相似试验